Pinnacle Wealth Planning Services’s Day One Biopharmaceuticals DAWN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19	Closed	-$407	–	2773
2026 Q1	$407	Buy	+19	New	+$268	﹤0.01%	2638

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pinnacle Wealth Planning Services's DAWN Position: Q2 2026 in Review

Pinnacle Wealth Planning Services sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 19 shares — an estimated $407 sold.

Pinnacle Wealth Planning Services first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $407 in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Pinnacle Wealth Planning Services reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Pinnacle Wealth Planning Services sold 19 Day One Biopharmaceuticals shares in Q2 2026, an estimated $407.
Pinnacle Wealth Planning Services first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Pinnacle Wealth Planning Services's Day One Biopharmaceuticals position peaked at $407 in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.